CDXI vs REGN: Which Stock is Better?
Side-by-side comparison of Cardax Inc and Regeneron Pharmaceuticals Inc in 2026
CDXI
Cardax Inc
$0.00
REGN
Regeneron Pharmaceuticals Inc
$746.00
Key Metrics Comparison
| Metric | CDXI | REGN | Winner |
|---|---|---|---|
| Market Cap | $0.00M | $79.71B | REGN |
| P/E Ratio | N/A | 18.18 | REGN |
| EPS (TTM) | $N/A | $41.47 | REGN |
| Revenue Growth | -0.3% | 0.0% | REGN |
| Gross Margin | 65.7% | 44.6% | CDXI |
Analyze CDXI
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CDXI or REGN a better investment?
Comparing CDXI and REGN: Cardax Inc has a market cap of $0.00M while Regeneron Pharmaceuticals Inc has $79.71B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CDXI and REGN?
CDXI (Cardax Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CDXI or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CDXI or REGN?
REGN has higher revenue growth at 0.0% vs -0.3% for CDXI.
Which company is more profitable: CDXI or REGN?
Cardax Inc (CDXI) has higher gross margins at 65.7% compared to 44.6% for REGN.
Which is the larger company: CDXI or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.71B compared to $0.00M for CDXI.
Should I buy CDXI or REGN in 2026?
Both CDXI and REGN have investment merit. CDXI trades at $0.00 while REGN trades at $746.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CDXI and REGN stock?
Key differences: Market Cap ($0.00M vs $79.71B), P/E Ratio (N/A vs 18.2x), Revenue Growth (-0.3% vs 0.0%), Gross Margin (65.7% vs 44.6%).